AGE RELATED MACULAR DEGENERATION (ARMD)
Clinical trials for AGE RELATED MACULAR DEGENERATION (ARMD) explained in plain language.
Never miss a new study
Get alerted when new AGE RELATED MACULAR DEGENERATION (ARMD) trials appear
Sign up with your email to follow new studies for AGE RELATED MACULAR DEGENERATION (ARMD), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Gut health hack: supplement shows promise for dry eyes
Symptom relief CompletedThis study tested whether a dietary supplement could improve dry eye symptoms by changing the bacteria in the gut. Twenty adults with dry eye disease took the supplement for 8 weeks. Researchers measured tear production and eye surface health before and after treatment. The goal …
Matched conditions: AGE RELATED MACULAR DEGENERATION (ARMD)
Phase: NA • Sponsor: Varol TUNALI • Aim: Symptom relief
Last updated Jun 27, 2026 09:06 UTC
-
Eye injection burden varies by disease, study finds
Knowledge-focused CompletedThis study looked at how much of a burden patients feel from repeated anti-VEGF eye injections for three different eye diseases: wet age-related macular degeneration, retinal vein occlusion, and diabetic macular edema. Researchers surveyed 393 patients about their treatment burde…
Matched conditions: AGE RELATED MACULAR DEGENERATION (ARMD)
Sponsor: Hospital Hietzing • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:04 UTC